Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.22 +0.73 (+2.76%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
News headline image
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
From Pfizer Inc.
Via Business Wire
News headline image
MarketBeat: Week in Review 12/05 – 12/09
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week. 
Via MarketBeat
Topics Economy Electric Vehicles Supply Chain
News headline image
Pfizer Declares First-Quarter 2023 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months. 
Via MarketBeat
News headline image
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
From Pfizer Inc.
Via Business Wire
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled with reports. In the winter issue of the Journal of... 
Via Newswire.com
News headline image
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults
From Pfizer Inc.
Via Business Wire
News headline image
Nanomedicine Market Size & Share Report 2022 : Reach at US$ 238.4 Bn and Grow at Healthy CAGR 10.1% During Forecast Period 2022-2028
"Emerging innovative technologies for drug delivery, the benefits of nanomedicine in various healthcare applications, and the increase in the demand for safe and inexpensive treatments drive the growth... 
Via SBWire
News headline image
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
From Pfizer Inc.
Via Business Wire
News headline image
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
From Roivant Sciences
Via GlobeNewswire
News headline image
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment 
Via MarketBeat
Topics Intellectual Property
News headline image
Longwood Healthcare Leaders to Bring Together Several Hundred Top Biotech and Pharmaceutical Leaders on Jan. 5-6, 2023
Longwood Fund, an early-stage life science venture firm, will convene several hundred top biotech and pharmaceutical leaders at its Pre-JPM Longwood Healthcare Leaders meeting, hosted virtually via... 
Via Newswire.com
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Nutraceutical Supplements Market to Witness Huge Growth : Glanbia, Pfizer, Bayer, DowDuPont
Understand focused approach and business strategies that competitors are keeping to reach target audience, Get one step closer to leaders and high growth emerging players of Nutraceutical Supplements... 
Via SBWire
Graphic design as a service Company Doozoo secures strategic investment partner, launches fresh branding and expands resource within USA to meet growing global demand.
Via Get News
News headline image
Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
From Arvinas Inc.
Via GlobeNewswire
What the Latest Science Says About COVID-19 Testing and Treatment
Via StatePoint Media
Topics Death
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Four Healthcare Stocks To Watch This Week
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue. 
Via MarketBeat
News headline image
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry. 
Via MarketBeat
Topics Intellectual Property
Glisser Agrees Strategic Partnership with American Express Global Business Travel
Via Get News
News headline image
Physicians for Informed Consent Challenges the Basis for COVID-19 Vaccine Mandates
According to Physicians for Informed Consent, new data raise serious concerns over the risks of hospitalization in people vaccinated with the COVID-19 vaccine. 
Via Newswire.com
Topics Death
The Dr. Erik Goluboff Scholarship for Future Medical Doctors Available in the United States
Via Get News
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
Learn more about Organicell Regenerative Medicine, Inc.from this latest report. 
Via TheNewswire.com
News headline image
NYSE:PFE Investor Alert: Investigation over Possible Securities Laws Violations by Pfizer Inc. ↗
San Diego, CA -- (SBWIRE) -- 11/10/2022 -- Pfizer Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii
Stay up-to-date with Drug Repurposing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
From Pfizer Inc.
Via Business Wire
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.